Develops the ATOM H1, a hardware device that integrates with cameras to create cryptographically signed images, ensuring authenticity through unique sensor fingerprinting and secure data binding. This technology addresses the growing need for verifiable digital media by enabling photographers, organizations, and platforms to capture, store, and share trusted images, preventing misuse and distortion in an era of pervasive digital manipulation.

HUI is a cloud-based platform that centralizes business process management, integrating various functions to streamline operations. This reduces the complexity of handling multiple systems, leading to enhanced decision-making and more efficient resource allocation.

Physios Biotech develops microphysiological systems (MPS) that replicate human organ functions and rare disease environments, utilizing advanced nanotechnology for high human extrapolation. Their technology reduces reliance on animal testing and accelerates drug development timelines by providing accurate safety evaluations and therapeutic assessments for rare cancers.